Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 10 studies | 26% ± 8% | |
| endothelial cell | 3 studies | 24% ± 5% | |
| Mueller cell | 3 studies | 37% ± 26% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 87% | 821.05 | 399 / 459 | 31% | 1.28 | 347 / 1118 |
| brain | 66% | 826.20 | 1747 / 2642 | 25% | 0.67 | 179 / 705 |
| adipose | 89% | 725.24 | 1076 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 53% | 46.57 | 47 / 89 | 28% | 0.62 | 251 / 901 |
| uterus | 37% | 86.79 | 63 / 170 | 12% | 0.95 | 55 / 459 |
| ovary | 26% | 51.72 | 47 / 180 | 17% | 0.47 | 74 / 430 |
| thymus | 5% | 4.30 | 32 / 653 | 28% | 1.50 | 170 / 605 |
| esophagus | 4% | 5.26 | 60 / 1445 | 15% | 3.31 | 28 / 183 |
| skin | 15% | 18.75 | 280 / 1809 | 3% | 0.12 | 13 / 472 |
| lung | 5% | 4.43 | 30 / 578 | 13% | 0.86 | 149 / 1155 |
| prostate | 14% | 16.89 | 35 / 245 | 2% | 0.03 | 9 / 502 |
| bladder | 10% | 28.86 | 2 / 21 | 5% | 0.19 | 23 / 504 |
| pancreas | 2% | 1.13 | 6 / 328 | 11% | 0.35 | 19 / 178 |
| blood vessel | 10% | 14.11 | 134 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 1% | 1.46 | 4 / 359 | 9% | 0.66 | 25 / 286 |
| intestine | 4% | 4.99 | 43 / 966 | 4% | 0.11 | 23 / 527 |
| adrenal gland | 3% | 6.29 | 8 / 258 | 4% | 0.13 | 10 / 230 |
| liver | 0% | 0 | 0 / 226 | 4% | 0.07 | 15 / 406 |
| muscle | 3% | 3.39 | 28 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.26 | 1 / 45 |
| heart | 2% | 1.62 | 13 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.05 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0090331 | Biological process | negative regulation of platelet aggregation |
| GO_0006508 | Biological process | proteolysis |
| GO_0001654 | Biological process | eye development |
| GO_0005576 | Cellular component | extracellular region |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0004222 | Molecular function | metalloendopeptidase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ADAMTS18 |
| Protein name | Alternative protein ADAMTS18 ADAM metallopeptidase with thrombospondin type 1 motif 18 (cDNA FLJ60448, highly similar to ADAMTS-18) A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-) ADAM metallopeptidase with thrombospondin type 1 motif 18 |
| Synonyms | ADAMTS21 |
| Description | |
| Accessions | ENST00000282849.10 [Q8TE60-1] H3BMG1 ENST00000562332.1 H3BTZ3 Q8TE60 L8ECP9 ENST00000562345.1 ENST00000449265.2 B4DEX3 |